Chrysin (5,7-dihydroxyflavone), a flavonoid present in diverse plants, has a backbone structure shared with the basic structure of the flavones, with additional hydroxyl groups that confers its antioxidant properties and effects at the GABAA receptor complex. However, whether these effects are due to the hydroxyl groups is unknown. Here we report the effects of chrysin or the flavone backbone (1 mg/kg) on rat behavior in the elevated plus-maze (EPM) and a locomotor activity test (LAT), as well as in the zebrafish light/dark test (LDT). Chrysin, but not flavone, increased entries and time in the open arms of the EPM, as well as time on white in the zebrafish LDT. These effects were comparable to diazepam, and were devoid of motor effects in both tests, as well as in the rat LAT. On the other hand, flavone increased risk assessment in the zebrafish LDT and rat EPM, suggesting effects threat information gathering; important species differences suggest new avenues of research. It is suggested that the specific effects of chrysin in relation to flavone are due to its free radical scavenging abilities and/or its action at the GABA A /benzodiazepine receptor complex. Preprint: https://doi.org/10.1101/575514; Data and scripts: https://github.com/lanec-unifesspa/chrysin 1/16 29 behavior. The basic flavone moiety has an hydrogen bond donor site, lipophilic pockets, 30 and an electron rich site (Marder and Paladini, 2002); this last is thought to be 31 important for the binding of both flavonoids and 1,4-benzodiazepines to the central 32 benzodiazepine (BZD) site at GABA A receptors (Marder and Paladini, 2002). Since the 33 chrysin hydroxyl groups are located in one region of the flavone basic ring that is 34 important for the steric interactions associated with binding, this flavonoid is expected 35 to bind BZD sites with a higher affinity than flavone. As a result, while chrysin is 36 2/16 65 measures in the study.
Introduction 1
Flavonoids are polyphenolic compounds present in diverse plants (Ghosh and Scheepens, 2 2009; Krafczyk et al., 2009) . The majority of these compounds have been linked with 3 protective effects against oxidative damage (Hwang and Yen, 2008; Wolfe and Liu, 4 2008), in addition to its pharmacological action on the Central Nervous System 5 (German-Ponciano et al., 2018) . Particularly, the flavonoid chrysin (5, 6 7-dihydroxyflavone) has been one of the most studied by its antioxidant properties 7 (Siddiqui et al., 2018) , but currently also due to its neuropharmacological actions 8 produced on specific brain structures implicated in neuropsychiatric disorders (Filho et 9 al., 2016; Bortolotto et al., 2018) . Chrysin has a backbone structure that consists in two aromatic rings (A and C), and 11 a phenyl B ring, which is attached to the second position of ring C and shares the basic 12 structure of the flavones, with an additional hydroxyl group in the 5 and 7 positions of 13 the A ring (Mani et al., 2017 ; Figure 1 ). The potential of chrysin to act as free radical 14 scavenger has been attributed to the presence of these hydroxyl groups (Sathiavelu et 15 al., 2009; Souza et al., 2015) , and it has been suggested that this functional group 16 represents the main action site of this flavonoid to produce a great variety of potential 17 therapeutic effects to ameliorate diverse physiological and psychiatric disorders (Sheela 18 and Angusti, 1995) . However, no studies have directly compared the effects of identical 19 doses of chrysin and the basic structure of flavones on the potential therapeutic effects 20 reported at preclinical research. 21 Chrysin exerts anxiolytic-like effects through action on the GABA A receptors 22 without the associated side effects (i.e. sedation, amnesia, myrelaxation) that have been 23 attributed to other GABA A modulators (benzodiazepines, ethanol, etc.); these effects 24 have been evaluated in behavioral models using rodents (Wolfman et al., 1994; Salgueiro 25 et al., 1997; Zanoli et al., 2000; Rodríguez-Landa et al., 2019) . Although it has been 26 suggested that presence of the hydroxyl groups in the chrysin structure is the 27 responsible for this pharmacological action, this effect has not been compared with the 28 effects produced by basic structure of the flavones in experimental tests of anxiety-like expected to produce a more potent anxiolytic-like effect due to both its higher affinity 37 to the BZD site and its free radical scavenging ability, the electron rich site of flavone is 38 expected to produce at least some level of anxiolysis due to the moderate affinity to the 39 BZD site.
40
In addition to mammalian model organisms used to study the anxiolytic-like effects 41 of diverse substances, non-mammalian models has been developed that allow researchers 42 to explore the potential therapeutic effects of drugs in a short time (Norton and 43 Bally-Cuif, 2010). The use of zebrafish in preclinical research in the 44 psychopharmacology field has increased recently. Biobehavioral assays of anxiety, such 45 as the rodent light/dark test (LDT), have been adapted to zebrafish, considering that 46 behavioral phenotypes are similar between rodents and zebrafish (Maximino et al., 47 2010a). Behavioral screens using zebrafish have evaluated the effects of clinically 48 effective anxiolytic drugs, including benzodiazepines (Maximino et al., 2011) and 49 ligands of both the central and peripheral BZD sites (Lima-Maximino et al., 2018) , 50 suggesting good pharmacological isomorphism and the ability of such screens to identify 51 potential anxiolytic drugs that can progress in the drug development pipeline. In 52 addition to increasing the toolbox of behavioral screens for psychoactive drugs, zebrafish 53 screens and biobehavioral assays also increase our understanding of the "core" 54 mechanisms of behavioral functions, such as fear and anxiety, that are altered in human 55 patients and shared between humans and rodents (Gerlai, 2014) .
56
The aim of the present study was to compare the effects of chrysin and the flavone 57 backbone (the basic structure of the flavone without the hydroxyl radical groups), using 58 the light/dark test (LDT) in zebrafish, as well as the rat elevated plus-maze (EPM) and 59 locomotor activity test. This could contribute to identify if anxiolytic-like effects 60 produced by chrysin are due to the presence of hydroxyl radicals in its basic structure, 61 which could impact in the specific design of novel molecules destined to 62 pharmacotherapy of anxiety. This manuscript is a complete report of all the studies 63 performed to test the effect of chyrsin, flavone, or diazepam on anxiety-like behavior in 64 rats and zebrafish. We report all data exclusions (if any), all manipulations, and all from Sigma-Aldrich Co (St. Louis MO, USA). Dimethylsulfoxide (DMSO) was acquired 88 from Golden Bell Reactivos (México City, México). Diazepam (CAS 439-14-5; Tocris 89 2805) was purchased from Tocris. Chrysin and flavone were dissolved in 5% 90 dimethylsulfoxide (DMSO) and injected i.p. Thirty-two rats were assigned to four 91 independent groups (n = 8/group). The vehicle group received 5% dimethylsulfoxide 92 (DMSO) solution (Golden Bell Reactivos, México City, México); a second group (CHR) 93 received 1 mg/kg chrysin; a third group (FLAV) received 1 mg/kg flavone; and a fourth 94 group (DZP) received 2 mg/kg diazepam as a positive control.
95
The dose of chrysin (1 mg/kg/i.p.) used in the present study was selected from 96 previous experiments of dose-response curves in rodent experimental models of anxiety, 97 including the elevated plus-maze (Rodríguez-Landa et al., 2019; German-Ponciano et al., 98 in press) where it was identified that this dose of chrysin possesses anxiolytic-like effects 99 similar to those produced by diazepam. To reduce the number of animals used in the was administered as the reference anxiolytic drug which reduces the anxiety-like 105 behavior in the EPM in Wistar rats (Rodríguez-Landa et al., 2019) . Sixty minutes after 106 the injection, the rats were evaluated in the elevated plus maze and then in the 107 locomotor activity test. Zebrafish were randomly drawn from the holding tank 108 immediately before injection and assigned to four independent groups (n = 12/group). 109 Groups were identical to those used for rats. The injection volume was 1 µL/0.1 g b.w. 110 (Kinkel et al., 2010) . The order with which groups were tested was randomized via 111 generation of random numbers using the randomization tool in 112 http://www.randomization.com/. Experimenters were blinded to treatment by using 113 4/16 coded vials for drugs. The data analyst was blinded to phenotype by using coding to 114 reflect treatments in the resulting datasets; after analysis, data was unblinded.
115
Apparatuses and methods.
116
Rat elevated plus-maze The rats were separately evaluated in the elevated plus 117 maze, and then in the locomotor activity test. On the testing day, the rats were brought 118 to the experimental room at 11:00 AM and left for 1 h to acclimate to the novel 119 surroundings. The behavioral tests began at 12:00 AM. The apparatus consisted of two 120 opposite open and closed arms set in a 'plus' configuration, and it was situated in an 121 illuminated room at 40 lux. The open arms were 50 cm length x 10 cm width, and the 122 closed arms were 50 cm length x 10 cm width, with 40 cm-high walls. The entire maze 123 was elevated 50 cm above the floor (Figure 2A ). To evaluate the effects of the After the elevated plus maze test, the rats underwent the locomotor activity test.
137
Approximately 2 min elapsed between tests.
138
Rat locomotor activity test. Each rat was individually placed in the locomotor 139 activity cage (44 cm length x 33 cm width x 20 cm height; Figure 3A ). The floor of the 140 cage was delineated into twelve 11 cm x 11 cm squares to evaluate spontaneous 141 locomotor activity, grooming, and rearing for 5 min. At the beginning of the test, the rat 142 was gently placed in one of the corners of the cage. The following variables were scored: 143 Zebrafish light/dark test. The light/dark preference (scototaxis) assay was 158 performed as described elsewhere (Maximino et al., 2010b; . Briefly, 30 159 min after injection animals were transferred individually to the central compartment of 160 a black/white tank (15 cm height X 10 cm width X 45 cm length; Figure 4A ) for a 161 3-min acclimation period, after which, the doors which delimit this compartment were 162 removed and the animal was allowed to freely explore the apparatus for 15 min. While 163 the whole experimental tank was illuminated from above by an homogeneous light followed by re-entry in the black compartment, or as a partial entry in the white 181 compartment (i.e., the pectoral fin does not cross the midline).
182
A digital video camera (Samsung ES68, Carl Zeiss lens) was installed above the 183 apparatus to record the behavioral activity of the zebrafish. Two independent observers, 184 blinded to treatment, manually measured the behavioral variables using X-Plo-Rat 2005 185 (https://github.com/lanec-unifesspa/x-plo-rat). Inter-observer reliability was 186 at least > 0.85.
187
Statistical analysis.
188
Data were analyzed using one-way ANOVAs with permutation tests, followed by 189 pairwise permutation tests with p-values adjusted for the false discovery rate. Analyses 190 were made in R (R Core Team, 2018), using the package 'coin' (Hothorn et al., 2006). 191 Outliers were detected using an a priori rule based on median absolute deviation (MAD) 192 of time on white (the main endpoint of the LDT) or time in the open arms (the main 193 endpoint of the EPM), with values above or below 3 MADs being removed (Leys et al., 194 2013) . Using this procedure, one outlier was removed from the flavone-treated group.
195
Open science practices.
196
Hypotheses and methods were not formally pre-registered. Data and analysis scripts can 197 be found at a GitHub repository (https://github.com/lanec-unifesspa/chrysin). 198
Results

199
Rat elevated plus-maze.
200
In the rat elevated plus-maze (Figure 2A) , a main effect of treatment was found for 201 entries in the open arms ( Figure 2B ; maxT = 2.4407, p = 0.05), with chrysin (p = 0.024 202 in relation to control) and diazepam (p = 0.023 in relation to controls) increasing this 203 variable. No effect was found for entries in the closed arm ( Figure 2C ; maxT = 1.0295, 204 p = 0.6392) or total entries ( Figure 2D ; maxT = 1.5331, p = 0.3679). A significant 205 effect was found for percentage of entries in the open arms ( Figure 2E ; maxT = 2.7848, 206 p = 0.02047), but differences disappeared after adjusting p-values in post-hoc contrasts. 207 Finally, a significant effect was found for time spent in the open arms ( Figure 2F ; maxT 208 = 2.6129, p = 0.03373), with chrysin (p = 0.0257) and diazepam (p = 0.0027) 209 increasing this variable. No effects were found for time spent head-dipping ( Figure 2F ; 210 maxT = 1.3025, p = 0.5123) or number of head-dipping events ( Figure 2G ; maxT = 211 0.853, p = 0.8). A significant treatment effect was found for time spent in SAP ( Figure 212 2H; maxT = 2.5326, p = 0.042), but meaningful differences disappeared after adjusting 213 p-values in post-hoc contrasts. Finally, a significant effect was found for SAP frequency 214 ( Figure 2I ; maxT = 3.2229, p = 0.005) with flavone (p = 0.0268 vs CTRL) and 215 diazepam (p = 0.0168 vs CTRL) reducing SAP. For variables with the same letter, the difference is not statistically significant. Likewise, for variables with a different letter, the difference is statistically significant.
Rat locomotor activity test.
217
In the rat locomotor activity test ( Figure 3A) , none of the treatments altered the 218 number of squares crossed in the arena ( Figure 3B ; maxT = 1.6296, p = 0.3139).
219
Grooming ( Figure 3C ; maxT = 1.5029, p = 0.3861) was not changed; a significant effect 220 was found for rearing ( Figure 3D ; maxT = 4.009, p = 0.0002), with the flavone 221 backbone increasing it (p = 0.0089 in relation to controls). C Grooming. D Rearing. For variables with the same letter, the difference is not statistically significant. Likewise, for variables with a different letter, the difference is statistically significant.
9/16
Zebrafish light/dark test.
223
In the zebrafish light/dark test ( Figure 4A ), chrysin (p = 0.0208) and diazepam (p = 224 0.0208), but not the basic structure of the flavone (p = 0.1487), significantly increased 225 (maxT = 3.7331, p = 0.0007321) the time spent into the white compartment ( Figure 4B ) 226 in relation to the control group. No significant changes were detected in the duration of 227 entries (maxT = 2.0981, p = 0.1243) or transitions (maxT = 0.67072, p = 0.891) to the 228 white compartment ( Figures 4C and 4D, respectively) , associated with the treatments. 229 On the other hand, the basic structure of flavone (p = 0.0201), but not chrysin (p = 230 0.06649) nor diazepam (p = 0.05843), significantly (maxT= 2.6404, p = 0.03119) 231 reduced risk assessment ( Figure 4E ) in relation to the control group. Diazepam (p = 232 0..319), but not chrysin (p = 0.6088) or flavone (p = 0.5098), increased erratic 233 swimming ( Figure 4F ; maxT = 3.9468, p = 0.002846). No significant changes were 234 observed in thigmotaxis ( Figure 4G ; maxT = 1.4946, p = 0.3913), or freezing duration 235 ( Figure 4H ; maxT = 2.3935, p = 0.06058) between treatments. For variables with the same letter, the difference is not statistically significant. Likewise, for variables with a different letter, the difference is statistically significant.
Discussion
237
The present study demonstrated that 1) the anxiolytic-like effect of flavonoid chrysin in 238 the rat EPM and zebrafish LDT, without locomotor effects, seems to be associated with 239 hydroxyl groups substituted in 5 and 7 positions of the A ring in the basic structure of 240 flavone; and 2) the basic structure of flavone is devoid of anxiolytic-like effects in the rat 241 EPM, but increases risk assessment in the zebrafish LDT and rearing in the rat 242 locomotor activity test. These results contribute to the knowledge that position of 243 hydroxyl groups in the basic structure of flavones is an important structural 244 11/16 characteristic to produces its pharmacological action on the central nervous system, and 245 suggest that a comparative approach is best suited to detect conserved drug effects 246 across species that are more likely to be shared with humans. needed to increase the number of head-dippings in the holeboard. This is in accordance 254 with a recent dose-response curve study where we showed that only the dose of 1 mg/kg 255 (i.p.) chrysin produced an anxiolytic like effect in male Wistar rats in the EPM 256 (German-Ponciano et al., in press ). These latter effects has been attributed to the 257 activation of GABAA receptors (Rodríguez-Landa et al., 2019) .
258
Similar effects were observed in the zebrafish LDT, a biobehavioral assay that is 259 based in the preference of zebrafish for dark environments (Serra et al., 1999) . This 260 behavior reflects the conflict between a motivation for staying in a "safe" place (i.e. 261 dark compartment) and an innate motivation to explore novel, potentially risky 262 environments (Magno et al., 2015) . The zebrafish LDT has been validated 263 pharmacologically as a model to screening diverse anxiolytic drugs (Maximino et al., 264 2011; Magno et al., 2015) . Clinically effective anxiolytic drugs that target different sites 265 of the GABA A receptor, like diazepam and other benzodiazepines, increase the time 266 spent in the light compartment of the apparatus (Gebauer et al., 2011; Maximino et al., 267 2011) , which has been considered as an anxiolytic-like effect at preclinical-research. 268 Moreover, drugs which indirectly target the central benzodiazepine site at GABA A 269 receptors -such as FGIN-1-27, a drug that promotes neurosteroidogenesis by activating 270 the translocator protein 18 kDa (TSPO) -have been shown to produce an 271 anxiolytic-like effect in the zebrafish LDT (Lima- Maximino et al., 2018) .
272
In the present study, the flavonoid chrysin increased the time spent in the light 273 compartment in comparison to the control group; however, the basic structure of the 274 flavone did not modify this variable. This variable is the main endpoint of the LDT, 275 and is altered by benzodiazepines and TSPO agonists (Sackerman et al., 2010; Stewart 276 et al., 2010; Maximino et al., 2011; Lima-Maximino et al., 2018) . This is concordant 277 with effects observed in the rat EPM. However, chrysin did not alter risk assessment 278 behavior in the present experiments, a variable that has been shown to be sensitive to 279 non-benzodiazepine treatments as well as to benzodiazepines (Maximino et al., 2014; 280 Lima- Maximino et al., 2018) . In a multivariate approach, risk assessment has been 281 shown to co-vary with other variables in the LDT, forming a separate cluster from 282 thigmotaxis and time on white (Maximino et al., 2014) ; thus, risk assessment is 283 sensitive to anxiolytic treatments, but represents a different dimension or factor in the 284 multivariate structure of zebrafish behavior in the LDT.
285 Surprisingly, the flavone backbone decreased risk assessment in the LDT and SAP in 286 the rat EPM, and increased rearing in the LAT. These outcomes are paradoxical; effects 287 on rearing are difficult to interpret, but it has been suggested (Lever et al., 2006 ) that 288 rearing is associated with environmental novelty, with a possible cognitive function in 289 information-gathering for escape behavior. However, risk assessment in the LDT and 290 SAP in the EPM can be interpreted as having an information-gathering function as well, 291 suggesting different mechanisms for rearing, on the one hand, and risk assessment 292 behavior in anxiety tests, on the other. Taken together, these results suggest that, 293 although not able to reduce the avoidance of potentially environments such as the open 294 arm of the EPM or the light compartment of the LDT tank, the flavone backbone is 295 able to reduce risk assessment behavior. Risk assessment has been suggested as a 296 12/16 cognitive component of anxiety-like behavior (Blanchard et al., 2011) , and is more 297 sensitive than spatiotemporal measures (time spent on open arms) in the EPM to detect 298 effects of serotonergic anxiolytics (Griebel et al., 1997) .
299
It has been reported that the generation of free radicals promote the inactivation of 300 the enzyme glutamate descarboxilase (responsable for the synthesis of GABA), leading 301 to a decrease of GABA concentrations and facilitating excitatory neurotransmission 302 (Singh et al., 2014) . Since chrysin, like most flavonoids, exert powerful antioxidant 303 effects, because it possesses highly reactive hydroxyl groups in its basic structure, this 304 confers a potent scavenging free radicals activity (Panche et al., 2016) . The 305 aforementioned could promote the GABAergic neurotransmission enhancing, similar to 306 clinically effective benzodiazepine drugs (Harvey, 2015) . Moreover, chrysin has been 307 reported to bind to benzodiazepine sites (Medina et al., 1990) and to inhibit aromatase 308 (Campbell and Kurzer, 1993) , suggesting that this flavonoid can exert more than one 309 effect in the GABA A /benzodiazepine receptor complex.
310
Overall the results of the present study show that, in zebrafish and rats, the 311 anxiolytic-like effect of the flavonoid chrysin could be related with the presence of the 312 hydroxyl groups in its basic structure. However, additional work is required to 313 determine the molecular mechanism through the flavonoid chrysin and others flavonoids 314 exert their potential therapeutic to ameliorate anxiety symptoms at preclinical research. 315
